Searched for
MANDIDEEP FACILITY
Textile sector: Time for a relook as tariff tantrum may soon be history? 5 textile stocks with upside potential of up to 27%- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on to
- USFDA issues Form-483 with 8 observations to Lupin's drug, API production facilities in Mandideep plant
- HEG to become world's largest graphite manufacturing unit by end of this year: Chairman Ravi JhunjhunwalaIn the second phase, new investment is being made by the unit in the state for manufacturing graphite anodes. In view of the increasing dem...07 Sep, 2022, 06.32 PM IST
- USFDA red flags Lupin for significant violations at MP unitThe USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.04 Oct, 2019, 05.27 PM IST
- Lupin gets warning letter from USFDA for Mandideep facilityShares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE.19 Sep, 2019, 11.23 AM IST
- Reduce Lupin, target Rs 840: Kotak Institutional EquitiesReduce Lupin at a price target of Rs 840.24 Apr, 2019, 01.52 PM IST
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...05 Dec, 2018, 02.00 PM IST
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...30 Jul, 2018, 02.30 PM IST
- Normalcy in operations to be restored soon: Crompton GreavesThe company had earlier announced that it has halted operations at its manufacturing unit at Mandideep in Madhya Pradesh after it was hit b...27 Jul, 2016, 12.24 PM IST
- Committed to close corrective action at Goa by December: LupinIt said that even if the US Food and Drug Administration decides to hold back approvals from the Goa facility it won't have much impact on ...13 Jun, 2016, 04.22 PM IST
- Lupin recalls over 54K vials of anti-bacterial injection in USThe ongoing voluntary recall is a class III recall and is for the US and Puerto Rico, according to the latest enforcement report on USFDA s...08 Jun, 2016, 05.02 PM IST
- Lupin terms USFDA observations "minor", brokerages say nothing to worry aboutThe company received three observations relating to violation of production norms at manufacturing facilities at Mandideep, Madhya Pradesh ...31 Mar, 2016, 06.39 AM IST
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.29 Mar, 2016, 06.39 PM IST
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.29 Mar, 2016, 03.34 PM IST
- Lupin gets US FDA nod for anti-depressantDrug maker Lupin has received US Food and Drug Association (FDA) approval for anti-depressant, it said on Wednesday.18 Mar, 2010, 02.05 AM IST
- Lupin plants get USFDA nod; co to sell new productsDrug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...21 Jan, 2010, 02.02 AM IST
- Citi maintains 'buy' on LupinCiti has maintained its 'buy' rating on mid-sized Indian pharma firm Lupin, and raised its target price to Rs 1,415, following the acquisit...03 Oct, 2009, 03.30 AM IST
- FDA observations not to affect supply: LupinDrug major Lupin on Friday said supply of products manufactured at its Mandideep facility will not be affected despite the US Food and Drug...15 Nov, 2008, 01.01 AM IST
- Lupin’s MP plant under USFDA scannerThe US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...14 Nov, 2008, 12.00 AM IST
Load More
